Embody, a U.S. telehealth weight management platform operated by Modern Metabolic Medicine, Inc., has announced the full pricing, renewal, cancellation, and safety terms for its Embody GLP-1 program. This announcement follows recent FDA regulatory actions regarding compounded medications.
Wilmington, Del., Nov. 5, 2026 — Embody, a U.S. telehealth weight management platform operated by Modern Metabolic Medicine, Inc., has announced the full pricing, renewal, cancellation, and safety terms for its Embody GLP-1 program. This announcement follows recent FDA regulatory actions regarding compounded medications. The program’s regular monthly rates are $299 for compounded semaglutide and $349 for compounded tirzepatide, with promotional starting prices of $49 and $99 a month on longer plans. Customers are required to cancel at least 72 hours before the next billing date to avoid charges. This disclosure comes in light of the FDA’s proposal to bar large outsourcing facilities from compounding semaglutide, tirzepatide, and liraglutide, and successive FDA warning letters since September 2025 concerning the promotion of compounded GLP-1 drugs online.
Compounded medications are prepared by state-licensed pharmacies for individual patients based on a prescription. They are not FDA-approved and have not been evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. Embody is not a medical provider. A prescription is issued only if an independent licensed clinician determines that treatment is medically appropriate, and approval is not guaranteed.
FDA Commissioner Marty Makary, M.D., M.P.H., emphasized the importance of not circumventing the FDA’s approval process in a March 3, 2026, agency statement. This distinction is why Embody’s published terms state that its medications are compounded, are not FDA-approved, and are prescribed only after an independent clinician review.
Embody GLP-1 Key Facts
-
Program type: Telehealth weight management program
-
Medications offered: Compounded semaglutide (GLP-1) and compounded tirzepatide (GLP-1/GIP), each as a once-weekly self-administered injection
-
Who prescribes: Independent licensed clinicians working through affiliated medical groups
-
Who prepares the medication: Partner compounding pharmacies, which ship directly to the patient
-
Plan lengths: Monthly, 3-month, 6-month, and 12-month plans (4, 12, 24, and 48-week supplies), from $49 a month for semaglutide and $99 a month for tirzepatide
-
Included in the price: All doses, the doctor consultation, unlimited one-to-one medical support, the written prescription, medication, and free shipping
-
Insurance: Not accepted; HSA and FSA cards accepted
-
Availability: Select U.S. states; the program may not be available in every state
Compounded GLP-1 medications have drawn steady regulatory attention over the past year. The FDA declared the national shortages of tirzepatide and semaglutide resolved in December 2024 and February 2025, which narrowed the conditions under which pharmacies may compound these drugs. The agency issued warning letters to telehealth and compounding companies over how compounded GLP-1 products were promoted. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk substances that large outsourcing facilities may use.
The questions behind this attention are practical: what “compounded” means, how it differs from an FDA-approved product, what a plan really costs after the first month, and how cancellation works. This release answers each of those questions for the Embody program.
What it means for consumers: As these rules are finalized, the supply and availability of compounded GLP-1 medications can change, including for people already on a plan. Anyone using a compounded program, including Embody, can ask which pharmacy fills their prescription, whether it operates as a state-licensed 503A pharmacy or a 503B outsourcing facility, and what happens to a prepaid plan if that pharmacy stops compounding the medication. Because Embody’s prepaid plans are non-refundable under its current terms, those answers matter before choosing a longer plan.
Compounded Vs. FDA-Approved GLP-1 Medications
FDA-approved GLP-1 products go through the agency’s full review of safety, effectiveness, and manufacturing quality before they reach patients. Compounded versions are prepared by a pharmacy for an individual prescription and do not go through that review. The FDA states that compounded drugs are not the same as FDA-approved or generic drugs, and that clinical trial results for approved products do not automatically apply to compounded versions.
Embody’s program uses compounded medications only. The company’s terms state that a clinician may prescribe an FDA-approved product when appropriate, but Embody does not fill or ship brand-name medications. Anyone comparing programs should check whether a platform offers compounded medication, FDA-approved medication, or both.
Embody GLP-1: What The Program Offers
Embody’s current store lists two compounded medications, each given as a once-weekly injection. The prescribing clinician decides which medication, starting dose, and dose changes fit each patient.
Compounded Semaglutide
Semaglutide is a GLP-1 receptor agonist. It acts on the body’s natural GLP-1 hormone pathway, which is involved in appetite, feelings of fullness, and how quickly the stomach empties after a meal. Treatment usually begins at a low dose that is raised gradually over several weeks to support tolerability. Embody’s compounded semaglutide is prepared by a partner pharmacy and has not been reviewed by the FDA as a finished product.
Compounded Tirzepatide
Tirzepatide acts on two hormone pathways, GLP-1 and GIP, both involved in appetite regulation and blood sugar balance. Like semaglutide, it is started at a low dose and increased step by step under clinician supervision. Embody’s compounded tirzepatide is also prepared by a partner pharmacy and is not FDA-approved.
Dosing And Formulation Details
Compounded injections are measured in syringe units, so the amount of medication in each dose depends on the strength of the vial. Embody says its price does not change when a dose changes within the same medication. Patients can ask their clinician or pharmacy for the vial concentration, the number of units per dose, any added ingredients, and the highest dose the program prescribes.
Partner Pharmacies
The company names four partner compounding pharmacies on its website: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Compounding Pharmacy in New York, and Triad Rx in Alabama. Patients can ask which pharmacy will prepare their order.
What The Monthly Price Includes
According to the brand, each plan includes all doses, the doctor consultation, unlimited one-to-one medical support, the written prescription, four weeks of medication per shipment, and free shipping. There is no separate membership fee. Lab work, if a clinician requests it, should be confirmed with the care team.
Embody Side Effects And Precautions
GLP-1 medications are prescription drugs, and safety depends on proper clinical screening, correct dosing, and careful handling. The FDA has reported receiving more than 1,700 adverse event reports linked to compounded semaglutide and tirzepatide as of May 2026, including cases tied to dosing errors. For this reason, patients should follow their clinician’s dosing instructions exactly and never change the number of units injected on their own.
In the same statement, Makary said the agency is “paying close attention to misleading claims being made by telehealth and pharma companies across all media platforms and taking swift action.” The FDA has also said its adverse event counts, about 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026, likely understate the true number, because some state-licensed pharmacies are not required to file reports. Because compounded doses are measured in syringe units that depend on vial strength, patients should confirm the concentration on every new vial and report persistent vomiting or severe abdominal pain promptly rather than waiting for a refill check-in.
The most common side effects of this medication class are digestive: nausea, vomiting, diarrhea, constipation, and stomach discomfort, usually most noticeable when starting or increasing a dose. FDA-approved labels for semaglutide and tirzepatide products also list serious but less common risks, including pancreatitis, gallbladder problems, low blood sugar in people taking certain diabetes medications, kidney problems linked to dehydration, and a boxed warning about thyroid C-cell tumors seen in rodent studies.
Anyone who develops severe stomach pain, persistent vomiting, signs of an allergic reaction, a lump or swelling in the neck, or other unexpected symptoms should stop use and contact a healthcare provider promptly. Emergencies require local emergency services, not a telehealth message.
How The Embody GLP-1 Program Works
The program runs online from intake to delivery:
-
Complete the health intake: Answer questions about medical history, current medications, and weight management goals on the official website.
-
Choose a medication preference and plan: Select semaglutide or tirzepatide and a plan length, then pay at checkout. Payment is collected before the clinical review is complete.
-
Clinician review: An independent licensed clinician reviews the intake, usually without a video visit, and decides whether a prescription is appropriate.
-
Pharmacy preparation and shipping: If approved, the prescription goes to a partner pharmacy, which prepares and ships the medication.
-
Ongoing care: Patients message the care team, report side effects, and complete refill check-ins before each new shipment.
Embody positions the program as one part of a broader routine that includes balanced nutrition, regular activity, and sleep. The medication does not replace those habits.
Embody GLP-1 Reviews: Separating Facts From Hype
Does Embody GLP-1 Work For Weight Loss?
Embody does not guarantee specific weight loss outcomes, as individual results may vary based on various factors. The brand positions the program as clinician-guided access to GLP-1 medication alongside nutrition and activity habits. Large clinical trials studied FDA-approved semaglutide and tirzepatide products, and no published trial has evaluated Embody’s finished compounded medications. Individual results vary and are usually judged over several months, since doses are raised gradually.
Embody Reviews: What To Look For Online
A large share of online “reviews” for GLP-1 programs are affiliate pages and sponsored articles. Readers get more from a review when it names the operating company, separates compounded from FDA-approved medication, states the renewal price as well as the first-month price, and explains the cancellation deadline. Reviews that describe compounded medication as identical to a brand-name drug do not reflect what the company or the FDA says.
Where To Sign Up: Official Website Vs. Look-Alike Pages
The official website is joinem.co. Embody at joinem.co is not affiliated with WebMD’s Embody weight management content or with other products that share the Embody name. Unofficial pages that use the name, including free website-builder pages, are not operated by the company. Card statements for Embody orders may show the payment processor name CareValidate rather than Embody, according to the company’s terms.
Embody GLP-1 Price In The United States
Embody offers a cash-pay program with flat pricing that stays the same across every dose. As part of its current Pre-Black Friday promotion, the official store lists both treatment options at reduced promotional rates:
-
Compounded Semaglutide: Starting from $49 a month (regularly $299 a month)
-
Compounded Tirzepatide: Starting from $99 a month (regularly $349 a month)
The lowest rates apply to longer plans. Each plan includes the doctor consultation, the written prescription, unlimited one-to-one medical support, and free shipping. The company states that the plan rate stays locked for as long as the customer remains on the plan, and says orders are typically prescribed and shipped within two days of approval. However, promotional pricing may change at any time, and customers should verify their plan details at checkout.
Billing And Auto-Renewal: How It Works
Plans renew automatically at the end of each cycle until canceled. Because billing runs every four weeks, staying on a 4-week plan for a full year means 13 charges rather than 12. The 12-month plan covers 48 weeks of medication, so a full calendar year of treatment needs one additional four-week supply.
Cancellation And Refunds, Step By Step
-
Cancel at least 72 hours before the next billing date to stop that charge through the account portal or customer support.
-
Ask for written confirmation of the cancellation and save it.
-
Understand the refund terms: The company’s refund policy states that payments, including prepaid plans, are final and non-refundable.
-
Medical ineligibility exception: If a clinician determines a patient is not medically eligible, the company refunds the unused portion after deducting services already provided.
Dispensed medication cannot be returned. The terms also include an arbitration agreement, which customers may opt out of by mailed written notice within 30 days of signing up.
Embody Shipping Across The United States
Medication ships from the partner pharmacy with free expedited delivery, according to the brand. The company’s terms state that delivery is handled by third parties and that timelines are not guaranteed. Patients can track orders and contact the care team through their account.
Who The Embody GLP-1 Program Is Designed For
-
Adults 18 and older who are seeking clinician-guided weight management support
-
People who prefer online intake and home delivery over in-person visits
-
Cash-pay buyers who are not relying on insurance coverage
-
People who understand that compounded medication is not FDA-approved and want flat pricing across doses
Who Should Check With A Doctor First
-
Anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
-
Anyone with a history of pancreatitis, gallbladder disease, kidney problems, or severe digestive conditions
-
People who are pregnant, planning a pregnancy, or breastfeeding
-
People taking insulin, sulfonylureas, or other diabetes medications, or any prescription medication
-
Anyone with a history of eating difficulties
-
The program is not intended for anyone under 18
Frequently Asked Questions
What Is Embody GLP-1?
Embody GLP-1 is an online weight management program in which independent licensed clinicians may prescribe compounded semaglutide or compounded tirzepatide, prepared and shipped by partner pharmacies.
Who Operates Embody?
Embody is operated by Modern Metabolic Medicine, Inc. The program is also known as JoinEm, after its website, joinem.co.
Is Compounded Semaglutide The Same As A Brand-Name Product?
No. Compounded semaglutide and tirzepatide are prepared by pharmacies for individual prescriptions and are not the same as FDA-approved or generic products.
How Often Is The Medication Taken?
Both medications are given as a once-weekly injection. The clinician sets the starting dose and any later changes.
Does The Price Change As The Dose Increases?
Embody says its flat rate covers all doses, so the price does not change when the dose changes within the same medication, and that the rate stays the same for as long as the customer remains on that plan.
Is A Prescription Guaranteed?
No. Payment is collected at checkout, and a clinician decides whether treatment is medically appropriate. If a patient is found ineligible, the unused portion is refunded after services already provided are deducted.
Does Embody Accept Insurance?
No. Embody is cash-pay. The brand says HSA and FSA cards are accepted; buyers can confirm eligibility with their plan administrator.
How Do I Cancel?
Cancel through the account portal or customer support at least 72 hours before the next billing date, and keep written confirmation.
Is Embody Available In Every State?
No. The company says the program may not be available in all states. Availability is confirmed during the intake.
What Side Effects Are Common?
Nausea, vomiting, diarrhea, constipation, and stomach discomfort are the most common, especially when starting or raising a dose. Severe or unexpected symptoms need prompt medical attention.
About Embody
Embody is a U.S. telehealth weight management platform operated by Modern Metabolic Medicine, Inc., 1811 Silverside Road, Wilmington, DE 19810, USA. Through the platform, independent licensed clinicians may prescribe compounded semaglutide or compounded tirzepatide, prepared and shipped by partner compounding pharmacies. Embody is not licensed to practice medicine and does not dispense FDA-approved brand-name medications. The program is available in select states through the official website, joinem.co, where customers can also reach the care team. Embody aims to provide accessible and transparent weight management solutions through telehealth, prioritizing patient safety and informed decision-making.
Media Contact
Kevin Show
Product Lead, HoneyFil
Email: support@joinem.co
Phone: (347) 269-4270
Modern Metabolic Medicine, Inc., 1811 Silverside Road, Wilmington, DE 19810, USA
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Individual experiences vary. Consult a qualified health care professional before starting any dietary supplement.
